We don't know whether the most recent response to this request contains information or not – if you are Sam Grigg please sign in and let everyone know.

Documents about the glycomannan and weight reduction claim

We're waiting for Sam Grigg to read a recent response and update the status.

Dear European Food Safety Authority,

In 2010, the EFSA published the following document:

Scientific Opinion on the substantiation of health claims related to konjac mannan (glucomannan) and reduction of body weight (ID 854, 1556, 3725), reduction of post-prandial glycaemic responses (ID 1559), maintenance of normal blood glucose concentrations (ID 835, 3724), maintenance of normal (fasting) blood concentrations of triglycerides (ID 3217), maintenance of normal blood cholesterol concentrations (ID 3100, 3217), maintenance of normal bowel function (ID 834, 1557, 3901) and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 1558) pursuant to Article 13(1) of Regulation (EC) No 1924/20061

This was produced by the EFSA Panel on Dietetic Products, Nutrition and Allergies.

Under the right of access to documents in the EU treaties, as developed in Regulation 1049/2001, I am requesting documents which contain the following information:

1. Any documents, notes or minutes of meetings from this panel that are related to the development of the above document.
2. In particular, any documents, notes, or minutes of meetings from this panel that are related to the claim that glycomannan reduces body weight.

Any information would be greatly appreciated.
Kind regards,
Sam

EFSA.public.access.to.documents, European Food Safety Authority

3 Attachments

Dear Sir or Madam,

 

Thank you for your request.

 

In order to process it according to the applicable procedural
requirements, we need you to state your full postal address, as well as an
alternative e-mail address, in case of difficulties encountered with the
platform you used to submit your request. May we kindly ask you to provide
us with these details at your earliest convenience?

 

Please note that, if we do not hear from you within five working days,
ultimately by Monday 11 December 2017 cob, your request will be deemed to
have been withdrawn.

 

Best regards,

 

EFSA Public Access to document Team

Legal and Assurance Services

 

Via Carlo Magno 1A

43126 Parma (Italy)

[1]www.efsa.europa.eu

[2]twitter.com/EFSA_EU [3][IMG]

[4]youtube.com/EFSAchannel [5][IMG]

 

This e-mail and its attachments is intended for the recipient(s) named in
the message.  If you are not an intended recipient, please let the sender
know immediately. Any disclosure or copying of the message content is
unauthorised and may be unlawful if you are not the intended recipient.

 

-----Original Message-----
From: Sam Grigg [[6]mailto:[FOI #4840 email]]
Sent: 30 November 2017 23:57
To: EFSA.public.access.to.documents
Subject: PAD 2017/0114 access to documents request - Documents about the
glycomannan and weight reduction claim

 

Dear European Food Safety Authority,

 

In 2010, the EFSA published the following document:

 

Scientific Opinion on the substantiation of health claims related to
konjac mannan (glucomannan) and reduction of body weight (ID 854, 1556,
3725), reduction of post-prandial glycaemic responses (ID 1559),
maintenance of normal blood glucose concentrations (ID 835, 3724),
maintenance of normal (fasting) blood concentrations of triglycerides (ID
3217), maintenance of normal blood cholesterol concentrations (ID 3100,
3217), maintenance of normal bowel function (ID 834, 1557, 3901) and
decreasing potentially pathogenic gastro-intestinal microorganisms (ID
1558) pursuant to Article 13(1) of Regulation (EC) No 1924/20061

 

This was produced by the EFSA Panel on Dietetic Products, Nutrition and
Allergies.

 

Under the right of access to documents in the EU treaties, as developed in
Regulation 1049/2001, I am requesting documents which contain the
following information:

 

1. Any documents, notes or minutes of meetings from this panel that are
related to the development of the above document.

2. In particular, any documents, notes, or minutes of meetings from this
panel that are related to the claim that glycomannan reduces body weight.

 

Any information would be greatly appreciated.

Kind regards,

Sam

 

-------------------------------------------------------------------

 

This is a request for access to information under Article 15 of the TFEU
and, where applicable, Regulation 1049/2001 which has been sent via the
AsktheEU.org website.

 

Please kindly use this email address for all replies to this request:
[7][FOI #4840 email]

 

If [8][EFSA request email] is the wrong address
for information requests to European Food Safety Authority, please tell
the AsktheEU.org team on email [9][email address]

 

This message and all replies from European Food Safety Authority will be
published on the AsktheEU.org website. For more information see our
dedicated page for EU public officials at
[10]https://www.asktheeu.org/en/help/officers

 

 

 

-------------------------------------------------------------------

 

 

References

Visible links
1. http://www.efsa.europa.eu/
2. http://twitter.com/EFSA_EU
3. https://twitter.com/efsa_eu
4. http://youtube.com/EFSAchannel
5. http://youtube.com/EFSAchannel
6. mailto:[FOI #4840 email]
7. mailto:[FOI #4840 email]
8. mailto:[EFSA request email]
9. mailto:[AsktheEU.org contact email]
10. https://www.asktheeu.org/en/help/officers

hide quoted sections

We don't know whether the most recent response to this request contains information or not – if you are Sam Grigg please sign in and let everyone know.